Label- and spectral-analysis-free detection of neuropsychiatric disease biomarker using ion-sensitive nanolaser

We demonstrate label- and spectral-analysis-free nanolaser biosensor, whose emission is changed by the surface charge. In this study, we applied this to sensing CRMP2 protein, which is expected to become a biomarker of neuropsychiatric disorder.